Medical Studies On Marijuana Treatment

Huntington’s Disease
Psychosis / Schizophrenia
Rheumatoid Arthritis
Bipolar Disorder
General Use
Parkinson’s Disease
Tourette’s Syndrome
Multiple Sclerosis

ALS (Lou Gehrig’s Disease)
1. ALS patients said marijuana supplied depression and anxiety, happy, and presented muscle peace PRO
“Pot has immunomodulatory [able to regulating immune functions] properties and effects upon excitotoxicity [process through which nerves are damaged] that declare that it may have a disease-changing part in ALS [amyotrophic lateral sclerosis, aka Lou Gehrig’s Disease]. There have also been some anecdotal reports suggesting that marijuana may be helpful in improving specific ALS symptoms…
STYLE/METHODS: We performed an anonymous survey of most ALS patients attending the Penn ALS Center from June 2013 to the current…
RESULTS: The survey was given to 127 people and 102 were completed (93% response rate). Altogether, 21% reported prior or current usage of medical marijuana to deal with their ALS symptoms.
CONCLUSIONS: Those of our people using marijuana report an extremely important treatment effect on several ALS symptoms.”
Apr. 29, 2014 – Jacob Kaufman, MD
Return to Top
Bipolar Disorder
1. Bipolar patients who also had marijuana use disorder (CUD) had significantly greater neurocognitive performance than those without CUD PRO
Raphael J. Braga, MD, Assistant Professor of Psychiatry at Hofstra North Shore-LIJ School of Medicine, et al., said the following in their May 2012 review entitled “Cognitive and Clinical Outcomes Related To Cannabis Use in Patients with Bipolar I Condition,” published in Psychiatry Research:
“the aim of the current study was to review medical and neurocognitive measures in individuals with bipolar disorder with a history of marijuana use disorder (CUD) versus those with no history of CUD…
Results from our analysis declare that subjects with record and bipolar disorder of CUDs exhibit significantly greater neurocognitive performance, especially on working memory, processing speed, and actions of interest…
These data could possibly be interpreted to suggest that marijuana use could have a beneficial impact on cognitive functioning in patients with severe psychiatric disorders. However, it is also possible that these results may be due to relevant interpersonal skills within the exchange of illicit drugs and the dependence on a specific degree of mental function.”
May 2012 -Raphael J. Braga, MD
2. Individuals with bipolar disorder report that pot works more effectively than conventional drugs. PRO
Lester Grinspoon, MD, Professor of Psychiatry in the Harvard Medical School, et al., published in a Apr.-June 1998 report called “the Utilization Of Marijuana as a Mood Stabilizer in Bipolar Disorder: Anecdotal Data and the dependence on Clinical Research” in Record of Psychoactive Drugs:
“The authors present case histories suggesting a quantity of individuals find marijuana (marihuana) useful in the treatment of these bipolar disorder. Some used it to treat both, despair, or mania. They stated that it helped reduce the unwanted effects of the drugs, or had been far better than conventional drugs. One person discovered that pot controlled her manic rages; she and her husband have worked to create it legally available as a medicine. Others explained the utilization of marijuana like a supplement to lithium (enabling reduced use) or for aid of lithium’s negative effects. Another scenario illustrates the fact medical marijuana users come in danger of charge, particularly when kids are encouraged to inform on parents by some drug prevention programs.
An analogy is drawn between that of lithium and cannabis today’s rank in the early 1950s, when its impact on mania were identified but there have been no controlled studies. In the event of weed, regulations has produced such studies nearly impossible, as well as the only available data is anecdotal. The possibility of weed being a therapy for bipolar disorder unfortunately can’t be fully explored in the present social situations.”
Apr.-June 1998 – Lester Grinspoon, MD
Return to Top
1. Cannabidiol inhibits proliferation of breast cancer cells PRO
Sean D. McAllister, PhD, Scientist at California Pacific Medical Center Research Institute, et al., reported the next inside their Aug. 2011 study entitled “Pathways Mediating the Results of Cannabidiol on the Reduction of Breast Cancer Cell Growth, Invasion, and Metastasis,” released in Breast Cancer Research and Treatment journal:
” There’s a general consensus in the subject of cancer research that targeting multiple paths that control tumor development is the better technique for the eradication of aggressive cancers. It’d be a great candidate for use in combination treatments with additional drugs previously utilized in the clinic because CBD has a minimal toxicity. Importantly, CBD is apparently speaking through a cellular system that adjusts the appearance of key transcriptional elements (e.g., Id1) that control breast cancer cell growth, migration, and attack. The experiments described within this manuscript not just define the trails that CBD is currently working through to handle breast cancer cell aggressiveness, but additionally show the efficiency of CBD in pre clinical models. A greater understanding of this technique can result in potential treatments for breast cancer patients, like the extra improvement of CBD analog synthesis.”
August. 2011 – Sean D. McAllister, PhD
CBD was taken from pot plants produced in the University of Mississippi.]
2. Pot-based medicine secured against chemotherapy-induced vomiting and nausea PRO
“AIMS: Despite progress in antiemetic therapy, many people still have problems with chemotherapy-induced nausea and vomiting (CINV). This is a pilot, randomized, double blind, placebo-controlled phase II clinical trial designed to measure the tolerability, early efficacy, and pharmacokinetics of an acute dose titration of the whole-seed weed-based medicine (CBM) containing delta 9 tetrahydrocannabinol and cannabidiol, drawn in conjunction with standard solutions within the control of CINV.
METHODS: People affected by CINV despite prophylaxis with typical anti-emetic treatment were randomized to CBM or placebo, through the 120 h post- chemotherapy time, included with standard anti-emetic treatment…
SUMMARY: Weighed Against placebo, CBM added to standard antiemetic therapy provided and was well accepted greater protection against delayed CINV. These results must be proved in a phase III clinical trial.”
Nov. 2010 – MD, Marta Duran
Double blind Study
3. Cannabidiol (THC:CBD) remove relieved pain in patients with advanced cancer MASTER
Jeremy R. Johnson, MBChB, former Medical Director in Mid Wales Severn Hospice and the Shropshire, et.
“the principal analysis of vary from baseline in mean pain Exact Rating Scale (NRS) report was statistically significantly in favor of THC:CBD in contrast to placebo…
This study shows that THC:CBD extract is suitable for pain relief in patients with advanced cancer pain not fully treated by strong opioids.”
Nov. Johnson, MBChB
Doubleblind Study
4. Cannabis extract (CE) and THC were well-accepted, but no differences in appetite or quality of life were available at the doses examined NC
“GOAL: To assess the effects of marijuana extract (CE), delta-9-tetrahydrocannabinol (THC), and placebo (PL) on hunger and standard of living (QOL) inpatients with cancer-associated anorexia-cachexia syndrome (CACS)…
CONCLUSION: CE in the oral dose given was well accepted by these patients with CACS. No differences in patients’ appetite or QOL were identified often at the levels examined between CE and THC or between CE, THC, and PL.”
July 2006 – Florian Strasser, MD
Double blind Study
5. Cannabinoids could prevent tumor cells’ expansion and have pain relieving result in cancer patients PRO
Manuel Guzman, PhD, Professor of Molecular and Biochemistry Biology at Madrid Complutense University, explained the following in his Oct. 2003 report entitled “Cannabinoids: Potential Anticancer Agents,” published within the journal Nature Reviews – Cancer:
“Cannabinoids — the active components of Cannabis sativa as well as their types — apply modern effects in cancer patients by stimulating appetite and by preventing nausea, vomiting and pain.
Furthermore, these substances have been proven to restrict tumor cells in culture and animal models’ growth by modulating key cell-signaling pathways.
Cannabinoids do not develop the generalized toxic effects of conventional chemotherapies, and are often well tolerated.”
March. 2003 – PhD, Manuel Guzman
6. An evaluation does not find convincing evidence to recommend marijuana for preventing nausea in cancer clients FRAUD
Richard H. Schwartz, MD, Clinical Professor of Pediatrics at Georgetown University, Eric A. Voth, MD, Chairman of the Company on Global Drug Coverage, et al., wrote these in their Feb. 1997 report called “Weed to Avoid Nausea and Vomiting in Cancer Patients: A Review of Clinical Oncologists” inside the Southern Medical Journal:
“Weed, if rescheduled by the Drug Enforcement Agency, will be the only Food and Drug Administration (FDA)-approved drug to be administered by smoking. American doctors need regular, factual information regarding probable use habits and potential negative effects of medical marijuana, and a factual full overview of the literature on the subject.
We shipped a review 500 American medical oncologists, to 1. We inquired whether and just how the oncologists could recommend marijuana inside the type of cigarettes, were it to be FDA-approved. Completed studies were acquired from 1,122 (75%) of the oncologists.
The percentages of oncologists who approved or recommended selected antiemetics over five times between 1992 and 1994 were 98% for 5 HT, antagonists, 6PERCENT for dronabinol (Marinol), and 1PERCENT for smoked marijuana. We also found that 332 (30%) of the oncologist-participants for this nationwide study reinforced rescheduling of marijuana for medical reasons; however, twothirds (67%) of the 332 respondents have been in favor of rescheduling estimated they might write significantly less than one prescription per month for marijuana cigarettes. A comprehensive literature review didn’t present powerful evidence to recommend marijuana being a needed antiemetic medication.”
7. Oncologists have good opinions to the utilization of marijuana to stop vomiting in cancer chemotherapy people SEASONED
Rick Doblin, PhD, President of the Multidisciplinary Association for Psychedelic Studies (ROUTES), and Mark A. R.
“A random-sample, confidential survey of the people of the American Society of Clinical Oncology (ASCO) was done in spring 1990 testing the perceptions and experiences of American oncologists concerning the antiemetic use of marijuana in cancer chemotherapy patients. The survey was sent to about onethird (N = 2,430) of most Usa-based ASCO members and gave a response rate of 43% (1,035).
Over 44% of the respondents report suggesting marijuana’s (illegal) usage for your control of emesis to one or more cancer chemotherapy patient. Nearly one half (48%) would recommend marijuana with a in their clients if it were appropriate. As a collection, participants regarded used marijuana to be somewhat more efficient as opposed to officially available common synthetic dronabinol ([THC] Marinol; Unimed, Somerville, NJ) and roughly as safe. Of the participants who expressed a viewpoint, many (54%) thought marijuana ought to be available by prescription.
These results keep on the question of whether marijuana has a ‘currently accepted medical use,’ at issue in an ongoing legal and administrative argument concerning whether marijuana in used form should be available alongside synthetic THC by prescription in common form. This study proves that oncologists’ experience with all the medical use of marijuana is less intensive, compared to regulatory authorities may actually have considered as well as their ideas of it are far more positive.”
September 1991 – PhD Level A, Rick Doblin. R. PhD, Kleiman
ONE. Marijuana ingredients enhanced intractable neurogenic signs such as for instance reduced kidney manage discomfort, muscles spasms PROFESSIONAL
Derick TO. Sort, Maryland, Teacher within the Division of Medical Neurology in the College of Oxford, et al., authored in a Feb. 2003 post entitled “An Initial Managed Research to Find Out Whether Entire-Grow Marijuana Ingredients May Enhance Intractable Neurogenic Signs” within the diary Medical Rehab:
“GOALS: to find out whether grow-produced marijuana medical ingredients (CME) may relieve neurogenic symptoms unresponsive to regular therapy, and also to evaluate undesireable effects…
Steps utilized: Individuals sign that is documented, well-being inebriation and ratings on the daily schedule utilizing analogue machines that are visual. At the conclusion of every two-week interval an onlooker ranked intensity and regularity of signs on statistical score machines, given regular steps of impairment (Barthel Catalog), feeling and knowledge, and documented negative activities.
OUTCOMES: pain alleviation related to each THC was not somewhat inferior to placebo. Muscles jerks reduced kidney control and spasticity were enhanced by CME in certain sufferers with one of these signs. Several individuals experienced inebriation and temporary hypotension using quick preliminary dosing of THC- .
FINDINGS: Marijuana medical ingredients may enhance symptoms unresponsive to remedies that are regular. effects that are unwanted side are usually well-tolerated and foreseeable. Larger-scale research are justified to verify these results.”
February. 2003 – T. MD, Sort
Double blind Review
TWO. Cannabis use assists the Thoughtful Investigational New Medication (IND) plan sufferers stay steady and consider less prescription medicines PROFESSIONAL
Ethan Russo, Maryland, Older Healthcare Consultant in the Cannabinoid Research Company, et al., mentioned in his research of several of the rest of the several lawful medical pot individuals within the Thoughtful IND program, entitled “Persistent Marijuana Use Within the Thoughtful Investigational New Drug Plan: A Study Of Advantages and Undesireable Effects of Lawful Medical Marijuana,” and printed within the Jan. 2002 version of the Diary of Marijuana Therapeutics:
” this study’s aim would be to analyze the entire wellness position of the SEVEN enduring sufferers within the [Thoughtful IND] plan of FOUR. This task offers the initial chance to study the long term ramifications of marijuana on sufferers who’ve utilized a dose of the standardised, warmth-sterilized excellent- supply that is managed of low grade cannabis regarding eleven to twenty-seven decades.
Outcomes show medical usefulness in these sufferers in managing persistent musculoskeletal discomfort, glaucoma, spasm and nausea. Most FOUR sufferers therefore are getting numerous less regular drugs than formerly, and are steady regarding their persistent problems.
Moderate modifications in lung purpose were seen in TWO sufferers, while number functionally substantial attributable sequelae were mentioned in just about any additional physical program analyzed within the research, including: MRI verification of the mind, lung perform tests, torso x ray, neuropsychological tests, hormonal and immunological assays, electroencephalography, P300 screening, background, and nerve medical evaluation.
These outcomes might help the supply of marijuana that is medical to some higher quantity of sufferers in require. We genuinely believe that marijuana could be an effective and safe medication using numerous recommended enhancements within the Thoughtful IND plan that is current.”
January. 2002 – MD, Russo
Go back to Best
ONE. Sublingual (underneath the language) dosages of THC and CBD created combined outcomes when used-to handle intraocular tension (IOP) NC
Et-al, Ileana Tomida Ophthalmology Professional. Authored within an 2006 post entitled “Aftereffect Of Sublingual Software of Cannabinoids on Tension: A Preliminary Research” within Glaucoma’s Diary:
“OBJECTIVE: The purpose of the research was to gauge the impact on intraocular tension (IOP) and also the security and tolerability of oromucosal management of the low-dose of delta-9-tetrahydrocannabinol (Delta-9-THC) and cannabidiol (CBD)…
FINDINGS: just one FIVE mg sublingual dosage of Delta 9 THC decreased the IOP briefly and was well-tolerated by many sufferers. Sublingual management of twenty milligrams IOP was not reduced by CBD, while a temporary improve IOP increase was created by forty milligrams CBD.”
March. 2006 – MD, Tomida
Double blind Review
Go back to Best
HIV products
ONE. Neuropathic pain happy with HIV PROFESSIONAL in-patients
Ronald T. Ellis, Maryland, PhD, Teacher In Home within the Division of Neuroscience in the College of Ca at North Park, et al., mentioned the next within their Aug. 2008 research entitled “Reviewed Medical Marijuana regarding Neuropathic Pain in HIV: A Randomized, Cross-Over Clinical Test,” printed in Neuropsychopharmacology:
“In a double blind, randomized test of the short term adjunctive therapy of pain in HIV- distal polyneuropathy, individuals obtained possibly used placebo or marijuana marijuana smoking…
Among completers, placebo was not somewhat higher using marijuana than pain relief. The percentage of topics attaining at-least 30% pain alleviation was again somewhat higher using marijuana (46%) when compared with placebo (18%). It had been figured reviewed marijuana was not usually hardly -accepted and efficient when added in-patients using clinically refractory discomfort because of HIV to concomitant medication treatment -connected neuropathy.”
August. 2008 – J. Doctor, Ellis, PhD
Double blind Review
TWO. Cannabis utilize created considerable escalation among HIV-positive in intake of food sufferers PROFESSIONAL
Maggie Haney, PhD, Connect Professor of Medical Neuroscience at Columbia College, et al., authored the next within their Aug. 15, 2007 research entitled “Dronabinol and Cannabis in hiv positive Pot Smokers: Calorie Intake, Feeling, and Rest,” printed within the Diary of Acquired Immune Deficiency Syndromes:
“Goals: This placebo-managed within-topics research examined dronabinol and cannabis eating feeling topography, intellectual efficiency, physiologic steps, and rest.
Techniques: hiv positive cannabis smokers (d EQUALS ten) finished TWO sixteen-time inpatient stages. Every dronabinol (FIVE and ten milligrams) and cannabis (2.0PERCENT and 3.9PERCENT [DELTA]NINE-tetrahydrocannabinol [THC]) dosage was given FOUR times everyday regarding FOUR times, but only one medication was energetic daily, therefore sustaining double blind dosing. Every effective cannabinoid situation was divided by several times of placebo fail.
Outcomes: As in contrast to placebo, dronabinol and cannabis measure dependently elevated bodyweight in HIV-positive and daily calorie intake cannabis smokers. Most cannabinoid problems created substantial inebriation, aside from reduced-dosage dronabinol (5 milligrams); the intoxication was ranked absolutely (like, “great medication impact”) using small proof of vexation with no disability of intellectual efficiency. Ramifications of cannabis and dronabinol were equivalent, besides that just cannabis (3.9PERCENT THC) enhanced rankings of rest.
Findings: These files claim that regarding hiv positive cannabis smokers, each dronabinol (at dosages EIGHT occasions present tips) and cannabis were well-tolerated and created considerable and equivalent raises in intake of food.”
August. 15 – PhD, Haney
THREE. Persistent neuropathic pain happy with HIV PROFESSIONAL in-patients
Jesse Abrams, Maryland, Teacher of Medical Medication in the College of Ca at Bay Area, et al., authored in his Feb. 13, 2007 post entitled “Marijuana in Unpleasant HIV-Connected Physical Neuropathy: A Randomized Placebo-Managed Test” within the diary Neurology:
“Goal: to look for the aftereffect of marijuana that is used about HIV’s pain – sensory neuropathy, and a discomfort design that is fresh…
Sufferers were arbitrarily given to smoking possibly marijuana (3.56PERCENT thc) or similar placebo smoking using the cannabinoids removed 3 times everyday for FIVE times…
Summary: effortlessly and Reviewed marijuana was well-tolerated happy chronic pain from HIV- associated neuropathy. The results are similar to dental medicines employed for pain that is persistent.”
February. 13 – Maryland, Abrams
Double blind Review
FOUR. Cigarettes cannabis decreased chronic pain in sufferers PROFESSIONAL
Jesse Abrams, Maryland, Teacher of Medical Medication in the College of Ca, Bay Area, et al., authored within their 2005 assembly summary INCHReviewed Marijuana Treatment regarding HIV-associated Unpleasant Peripheral Neuropathy: Outcomes Of a Randomized, Placebo-managed Medical Test,” printed within the Diary of the Worldwide Organization regarding Marijuana as Medication:
“Reviewed cannabis works well in decreasing severe discomfort in addition to persistent continuing neuropathic pain within the fresh pain design. The degree of the reaction of the pain that is neuropathic is comparable to what’s observed a popular healing treatment for neuropathy, using gabapentin.”
2005 – MD, Abrams
FIVE. HIV sufferers statement that cannabis helps reduce melancholy and nervousness, enhanced hunger, happy discomfort, and much more NC
Diane Prentiss, mum, MPH, et al., authored the next within their post entitled “Designs of Cannabis Use Among Individuals using HIVORhelps Adopted in a Public-Health Care Environment,” printed within the Jan. 2004 problem of Diary of Acquired Immune Deficiency Syndromes (JAIDS):
“Goals: to look at designs and frequency of recognized advantage and used cannabis and also to evaluate medical and market facets related to cannabis use in a public-health treatment environment…
Outcomes: General frequency of used cannabis in the earlier month was 23PERCENT. Documented advantages incorporated alleviation of anxiousness andORor melancholy (57%), enhanced hunger (53%), elevated enjoyment (33%), and pain relief (28%). Current utilization of cannabis was absolutely related to current utilization and serious sickness of booze and adversely related to being Latino.
Findings: The results claim that companies be recommended to evaluate regularly and greater comprehend sufferersA signs regarding personal-management of marijuana. Provided the frequency that is projected, more official portrayal of effect and the designs of marijuana use to ease HIV- signs that are connected is justified. Medical tests of noncombustible and reviewed cannabis are essential to look for cannabinoids’ part using possible like a course of brokers to enhance quality of health and life care results among sufferers using HIVANDsupports.INCHES
January. 2004 – MPH, Prentiss
SIX. HIV sufferers using cannabis in tablet and reviewed types possess enhanced defense perform PROFESSIONAL
Jesse Abrams, Maryland, Teacher of Medical Medication in the College of Ca, Bay Area, et al., authored the next within their post INCHshort term Ramifications Of Cannabinoids in-Patients using HIV 1 Disease: A Randomized, Placebo-managed Medical Test,” printed Aug. 2003 within the diary History of Internal Medicine:
“Findings: Reviewed and dental cannabinoids [ cannabis ] didn’t be seemingly hazardous in individuals with HIV disease regarding CD4 counts HIV RNA amounts, or inhibitor levels over a 21 day therapy.”
The associated INCHSummaries Regarding Sufferers” supplied by the diary mentioned:
” getting cannabinoids that was Sufferers [reviewed defense perform ] experienced enhanced in contrast to these receiving placebo. Additionally they acquired about FOUR lbs more normally than placebo being received by these sufferers.”
August. 2003 – MD, Abrams
SEVEN. Cannabis use could cause normal employ and lung issues might damage HIV sufferers DISADVANTAGE
Jesse G. Tashkin, Maryland, Overseer of the Lung Function Labs at UCLA, mentioned the next in his Summer 2001 post entitled “Ramifications Of Reviewed Cannabis about the Lung and Its Own Defense Protection: Ramifications for Medical Use Within HIV-Contaminated Individuals,” printed in Diary of Marijuana Therapeutics:
“Regular cannabis use may cause lung irritation throat injuries and reduced lung protection against disease. Chronic cannabis utilization of specific importance to sufferers using AIDS’s main possible lung effects is superimposed lung disease, that could be lifethreatening within the individual that was significantly immonocompromised.
Because of THC’s effect, the chance that cannabis use that is normal might improve development of HIV disease alone must be viewed, though this chance remains untouched up to now.”
Summer 2001 – Jesse G. Tashkin
EIGHT. Cell-culture research display opposition is lowered by cannabis to disease, but individual research have to decide long term effects NC
Man A. PhD, Cabral, mentioned the next in his Summer 2001 post entitled ” Cannabinoids and Cannabis: Results on Infection, Defenses, and helps,” printed in Diary of Neurology:
“The collective information acquired through cell-culture research utilizing numerous defense mobile communities removed from creatures or humans, as well as these acquired utilizing dog types of disease, are in line with the proposal that cannabis and cannabinoids change resistant cellular perform and certainly will apply bad results on opposition to infection in humans…
Nevertheless, studies and several controlled epidemiological have now been performed to link the immunosuppressive ramifications of cannabinoids or cannabis smoking about viral illness in people or the occurrence of infection.
Obviously, extra analysis to solve the long term immunological effects of cannabis and cannabinoid use because they relate to infection in people to opposition is justified.”
Summer 2001 – Man A. Cabral
Go back to Best
Huntington’s Illness
ONE. CBD discovered to not become toxic but inadequate at decreasing Huntington’s Illness signs NC
John Y. Consroe, PhD, Professor Emeritus within the Division of Pharmacology and Toxicology in the College of Az, et al., authored the next within their Nov. 1991 post entitled “Managed Clinical Test of Cannabidiol in Huntington’s Illness,” printed within the diary Pharmacology, Biochemistry and Conduct:
“centered on motivating initial results, cannabidiol (CBD), a significant nonpsychotropic component of Marijuana, was examined regarding systematic effectiveness and security in fifteen neuroleptic-free sufferers using Huntington’s Illness (HD). The results of dental CBD (10 milligrams/kilogram/evening for SIX weeks) and placebo (sesame oil for SIX weeks) were determined regular under a double blind, randomized cross over style…
In neuroleptic- patients using high-definition, CBD, at a typical daily dosage around 700 milligramsORevening for SIX months, was nor symptomatically efficient neither toxic to sum up.”
November. 1991 – F. Consroe
ere two times as apt to be internationally cognitively reduced DISADVANTAGE
Anthony PhD Teacher of Psychiatry in Toronto’s College wrote within their 29, 2011 post INCH Effects on Intellectual Perform in-Patients using Several Sclerosis” in Neurology of Marijuana:
“considering the fact that Microsoft is related to degeneration that is intellectual, this study’s purpose was to look for marijuana use’s neuropsychological ramifications in this populace.
Outcomes: Marijuana consumers done much more badly on steps of working-memory information-processing pace, govt functions than non-users. They certainly were additionally not two times as unlikely as non-users to not become unclassified as internationally cognitively disadvantaged.”
Marly. 29 – Maryland, Feinstein, PhD
SEVEN. Sativex spasticity that was enhanced brought on by M-S PROFESSIONAL
Alena Novotna, Maryland, et al., mentioned the next within their Mar. INCH, 2011 research entitled “A Randomized, double blind, Placebo-managed, Similar-team, Overflowing-style Research of Nabiximols (Sativex), as add on Treatment, in Topics using Refractory Spasticity Brought On By Several Sclerosis,” printed within the Western Record of Neurology:
“Spasticity is just a crippling problem of many sclerosis, impacting numerous sufferers using the situation. Topics were handled using nabiximols [ Sativex ], as add-on in one single, treatment – method that was impaired… This research indicates Sativex to enhance spasticity in-patients who’d didn’t react acceptably to antispasticity drugs that were additional…”
Marly. ONE, 2011 -Alena Novotna, Maryland
Double blind Review
EIGHT. Sativex spasticity that was enhanced brought on by M-S PROFESSIONAL
Jeremy R. Manley, doctor, previous Healthcare Representative in the Shropshire and Mid-Wales Severn Hospital, et al., mentioned the next within their Nov. FIVE, 2009 research entitled “Multi-Center, Double Blind, Randomized, Placebo-Managed, Similar-Team Research of the Effectiveness, Security, and Tolerability of THC:CBD Remove and THC Remove in-Patients using Intractable Cancers-Associated Discomfort,” printed within the Diary of Discomfort and Sign Management:
“This research compared the effectiveness of the tetrahydrocannabinol (THC) extract, an analgesic system modulator that was endocannabinoid, along with a extract in reducing discomfort in-patients using cancers that was sophisticated. As a whole, 177 individuals using melanoma discomfort, who skilled analgesia that was insufficient entered a two -week, multi-center, double-blind, randomized that was, placebo-managed, similar-team test…
Two times as numerous sufferers getting THC:CBD confirmed a reduced amount of over 30% from standard discomfort NRS rating in comparison with placebo (23 [43%] vs. twelve [21%])… This research suggests that THC remove is effective regarding pain relief in-patients using sophisticated cancers discomfort not completely happy by opioids that are powerful.”
November. FIVE, 2009 – R. MD, Manley
Double blind Review
NINE. Marijuana-dependent medication (CBM) discovered more efficient than placebo regarding decreasing Microsoft spasticity PROFESSIONAL
Christine Collin, Maryland, Older Advisor in Neuro-rehab in the Noble Berkshire and Fight Hospitals, et al., authored the next within their post INCHRandomized Controlled Test of Marijuana-Dependent Medication in Spasticity Brought On By Several Sclerosis,” printed within the Mar. 2007 Western Record of Neurology:
“Signs associated with spasticity are typical in several sclerosis (M-S) and certainly will be challenging to deal with. We’ve researched security, the effectiveness of the standardised… Marijuana-dependent medication (CBM) comprising delta-NINE tetrahydrocannabinol (THC) and cannabidiol (CBD), upon spasticity in Microsoft. An overall total of 189 topics using particular Microsoft and spasticity were randomized to get daily dosages of energetic planning (d EQUALS 124) or placebo (d EQUALS 65) in a double-blind research more than 6 months…
The effectiveness evaluation that is main… Confirmed the planning that was effective to not become somewhat inferior…
We determine this CBM [ marijuana -dependent medication] might signify a fresh broker that is good regarding therapy of spasticity in MS’s systematic reduction.”
Marly. 2007 – MD, Collin
Double blind Review
ten. Cannabinoids discovered to somewhat enhance spasticity in Microsoft sufferers, who experienced the medicines were useful NC
Steve S. Zajicek, PhD, Teacher of Medical Neuroscience in the Neurology Investigation and Clinical Trials Device of the Peninsula Medical College in the College of Plymouth, et al., authored the next in a Dec. 2005 post entitled “Cannabinoids in Several Sclerosis (CAMERAS) Research: Security and Effectiveness Information regarding twelve Weeks Follow-Up” within the Diary of Neurology, Neurosurgery and Psychiatry:
“GOAL: to check the usefulness and long haul security of cannabinoids in several sclerosis (M-S), in a follow-up towards the primary Cannabinoids in Several Sclerosis (CAMERAS) research…
OUTCOMES: Purpose to deal with evaluation of information in the 80PERCENT of sufferers followed-up for twelve months confirmed proof of a little therapy impact on spasticity as calculated by alter in Ashworth rating to twelve weeks from standard… There clearly was effective data regarding therapy ramifications of Delta(NINE)-THC on several facets of impairment. There have been no security issues that are main. General, sufferers experienced these medicines were in managing their illness useful…
FINDINGS: These information supply restricted proof of cannabinoids to get a long term therapy aftereffect. An extended period placebo-controlled research has become needed seriously to create whether cannabinoids might have a job beyond sign amelioration in Microsoft.”
December. 2005 – P. Zajicek
Double blind Review
eleven. Sativex somewhat enhanced spasticity brought on by M-S PROFESSIONAL
Derick TO. Sort, Maryland, Teacher within the Division of Medical Neurology in Oxford’s College wrote the next within an 2004 post entitled “Do Marijuana-dependent Particular Results Or Medical Ingredients Possess Common on Signs in Several Sclerosis? A Double-blind Placebo,, Randomized -managed Research on 160 Sufferers,” printed within the diary Multiple Sclerosis:
“the main outcome measure was a Analogue Size (VAS) rating for every individualis many difficult sign. Extra steps incorporated steps of knowledge, impairment, feeling, rest and exhaustion, and VAS ratings of additional signs. Subsequent CBME [marijuana-dependent medical remove] the main sign rating decreased from imply (ze) 74.36 (11.1) to 48.89 (22.0) subsequent CBME and from 74.31 (12.5) to 54.79 (26.3) subsequent placebo [ns].
Spasticity VAS ratings were somewhat decreased by CBME (Sativex) when comparing to placebo (P=0.001). There have been no substantial undesireable effects on feeling or knowledge and inebriation was not usually intense.”
August. 2004 – T. MD, Sort
Double blind Review
twelve. Orally given enhanced flexibility in-patients using M-S PROFESSIONAL and marijuana decreased jerks
Et al., Claude Vaney Healthcare Representative of the Nerve Rehab and Microsoft Centre Europe, authored within an 2004 post entitled “Effectiveness of Tetrahydrocannabinol to Regular Antiemetic Treatment in-Patients Refractory. Effectiveness, Safety of an Given Marijuana Remove in-Patients A Randomized, double blind, Placebo-managed, Crossover ResearchINCH within the diary Multiple Sclerosis within the Therapy of Spasticity:
“Within The fifty sufferers incorporated handle evaluation established -to- in to the purpose, there have been no statistically important variations related to active-treatment when compared with placebo, but developments towards active-treatment were observed regarding spasm regularity, flexibility and dealing with rest.
Within the 37 sufferers (per-process established) who obtained at-least 90PERCENT of the recommended dosage, enhancements in spasm regularity (G = 0.013) and flexibility after eliminating an individual who dropped and ceased jogging were observed (G = 0.01). Negative activities that are small were serious during active-treatment and somewhat more regular, and poisoning signs, that have been not usually intense, were obvious within the stage that is energetic.
SUMMARY: A standardised Marijuana sativa seed get improve flexibility using bearable unwanted effects in Microsoft sufferers using continual spasticity not answering additional medicines and may reduce spasm regularity.”
August. 2004 – MD, Vaney
Double blind Review
thirteen. Marijuana- medication ingredients that are dependent assists Microsoft sufferers using urinary-tract signs PROFESSIONAL that is reduce
Ciaran MICHAEL. Brady, Professional Registrar in Urology at Edith Cavell Clinic, et al., authored the next within an Aug. 2004 post entitled “A-Tag Preliminary Research of Marijuana-dependent Ingredients regarding Kidney Disorder in Sophisticated Multiple Sclerosis,” printed within the diary Multiple Sclerosis:
“nearly all sufferers using multiple sclerosis (M-S) create difficult reduce urinary-tract signs (LUTS). Historical studies claim that LUTS may be alleviated by marijuana, and receptors within nervous-system and the kidney are medicinal goals that are possible. Within an test that was available we examined the security, dosage variety tolerability, and effectiveness of two entire -place ingredients of Marijuana sativa in-patients using Microsoft that was sophisticated and LUTS.
Bladder emergency, the amount and amount of incontinence attacks, regularity and nocturia most reduced somewhat subsequent therapy (G Moderate and reduced dosages of vaporized marijuana decreased neuropathic discomfort PROFESSIONAL
Et al., Barth Wilsey Overseer of the College of Ca at Davis Medication Research Middle, mentioned the next within their 2013 research entitled “Low-Dose Vaporized Marijuana Somewhat Improves Pain,” printed within Pain’s Diary:
“We performed a double-blind, placebo that is -managed, crossover research analyzing the medication effectiveness of marijuana that is vaporized in topics, nearly all who experienced pain despite conventional therapy. Thirty nine individuals using main and peripheral neuropathic pain experienced a standardised process of breathing possibly moderate dosage (3.53%), low-dose (1.29%), or placebo marijuana…
A medication reaction was shown by combined results regression designs to vaporized marijuana. There clearly was no factor between your two energetic dosage groups’ outcomes (g”>>0.7)… [DO]annabis offers medication effectiveness using the reduced dose as efficient a pain-reliever whilst the moderate dosage, for several intents and reasons. Results that are psychoactive were minimum and nicely- and results that are neuropsychological were reversible within 1–2 hrs and easily of restricted length. Vaporized marijuana, actually at dosages that are reduced, might found therapy- pain to a fruitful choice regarding sufferers.”
February. 2013 – MD, Wilsey
Double blind Review
THREE. Reviewed marijuana 3 times each day enhanced rest PROFESSIONAL and reduced pain
Tag A. Ware, MD et al., mentioned the Aug. 30, 2010 following within their research entitled “Reviewed Marijuana regarding Chronic Pain: A Randomized Test,” printed within the Association Diary:
“Grownups using article-distressing or post-surgical neuropathic pain were arbitrarily designated to get marijuana at several potencies (0%, 2.5%, SIX% and 9.4% tetrahydrocannabinol) over several 14 day intervals in a crossover test. Individuals consumed just one 25-milligrams dosage via a tube 3 times everyday in every routine, followed closely by a-time washout interval for that initial several times. Everyday typical discomfort strength was calculated utilizing an eleven-stage score level that was number.
Just one breathing of 25-mg of 9.4PERCENT tetrahydrocannabinol natural marijuana 3 times was well-tolerated and everyday regarding several times decreased the strength of discomfort, enhanced rest.”
August. 30, 2010 – A. MD, Ware, MSc
Double blind Review
FOUR. Higher and reduced dosages of marijuana that was used relieved pain of triggers PROFESSIONAL that was varied
Barth Wilsey, doctor, Overseer of the College of Ca at Davis Medication Research Middle, et al., mentioned the next in his Summer 2008 research entitled “A Randomized, Placebo-Controlled Cross Over Test of Marijuana Smoking in Neuropathic Pain,” printed within the Diary of Discomfort:
“This researchis goal was to look at the effectiveness of two dosages of used marijuana on discomfort in individuals using neuropathic pain of various roots (e.g., bodily upheaval to neural packages, spinal-cord injuries, many sclerosis, diabetes). In a double blind, trial individuals that were randomized obtained possibly low-dose, higher- dose
Thirty eight individuals experienced a standardised process of cigarettes possibly higher-dosage (7%), reduced-dosage (3.5%), or placebo marijuana; of those, 32 finished most several cigarettes periods. A medication reaction was shown by the research to smoking marijuana without any factor between the high-dose smoking and also the reduced. The research figured each higher and reduced marijuana dosages were in reducing pain of varied triggers effective.”
Summer 2008 – MD, Wilsey
Double blind Review
FIVE. Cannabis discovered to each decrease and improve capsaicin-caused discomfort (shot of soup pepper component) based on dosage NC
Tag Wallace, Maryland, Teacher of Anesthesiology in the College of Ca at North Park, et al., mentioned the next within their Nov. 2007 post entitled “Dosage-Reliant Ramifications Of Reviewed Marijuana on Capsaicin-Caused Discomfort and Hyperalgesia in Healthier Volunteers,” printed within the diary Anesthesiology:
” within this type of individual fresh discomfort, to sum up, marijuana that was reviewed was proven to possess a postponed biphasic [two-phase] impact on pain ratings caused by capsaicin [ pepper warmth shot in to the epidermis]. The reduced dosage [of cannabis] experienced zero impact, the moderate dosage somewhat decreased the discomfort somewhat elevated… Number findings about used marijuana on medical discomfort states’ medication effectiveness could be produced from this research whilst the connection between medication results in medical discomfort says and fresh discomfort is unfamiliar.”
November. 2007 – MD, Wallace
Double blind Review
SIX. Marijuana-dependent medications created substantial enhancements in rest and pain intensity in-patients using brachial plexus avulsion PROFESSIONAL
Jonathan UTES. Berman, mum, Contacting Anaesthetist in the Regal National Orthopaedic Clinic, et al., authored the next in a Dec. 2004 post entitled “Effectiveness of Two Cannabis-Based Medical Ingredients regarding Alleviation of Main Neuropathic Pain from Brachial Plexus Avulsion: Outcomes Of a Randomised Controlled Test” within the diary Discomfort:
“the aim was to research cannabis’ potency -dependent medications regarding therapy of persistent pain root avulsion. This problem is a superb individual type of main neuropathic pain because it signifies an abnormally homogenous team when it comes to physiological area of individual census and injuries, discomfort explanations…
The measure that is main was the suggest discomfort intensity rating therapy of over the last seven days. Outcome measures that were supplementary incorporated pain-related standard of living checks. The outcome measure that was main didn’t drop from the two factors described within our speculation. Nevertheless, each steps of rest and this calculate confirmed enhancements that were statistically significant.
The research medicines were usually well-tolerated using the most of activities that were undesirable, solving automatically and including inebriation kind responses, being moderate to reasonable in intensity. Research of extended length in pain have to verify a scientifically related, enhancement within this condition’s therapy.”
December. 2004 – S. Berman
Double blind Review
SEVEN. Sufferers report enhancement in discomfort, rest, and feeling after marijuana utilize PROFESSIONAL
Tag A. Ware, MSc, Overseer of Study in the Magill College Health Center (MUHC) Pain Center in Europe, et al., authored the next in a Mar. 2003 post entitled “Marijuana Utilize for Persistent No-Melanoma Pain: Outcomes Of a Potential Study” within the diary Discomfort:
“There’s been a in curiosity about medical marijuana in Europe. A survey study was performed by us to look for the present frequency of medical marijuana use among sufferers using persistent no-melanoma discomfort, to estimation regularity and the dosage dimension of marijuana use, and also to explain the primary signs that alleviation had been wanted…
Of the 32 matters who utilized marijuana regarding discomfort, seventeen (53%) utilized several puffs or less at every dosing period, ten (25%) reviewed an entire marijuana smoke (joint) and several (12%) reviewed several joint. Several (22%) of those topics utilized marijuana more often than once daily, several (16%) utilized it daily, ten (25%) utilized it regular and eight (28%) utilized it seldom. Rest discomfort and feeling were most often documented as enhancing using marijuana use, and Ahigher’ and jaws that is dried were the absolute most generally documented unwanted effects. We determine that marijuana use is predominant one of the persistent no-melanoma discomfort populace, using substantial variability within the quantities utilized, to get a wide selection of signs.”
Marly. 2003 – A. Ware
Go back to Best
Parkinson’s Illness
ONE. Reviewed marijuana created enhancements without any substantial undesireable effects PROFESSIONAL in-patientsA Parkinson’s signs
Et al., Itay Lotan doctor within the Neurology division at Rabin Clinic in Israel, mentioned the next within their Mar.ANDRate. 2014 study entitled “Weed (Medical Cannabis) Therapy regarding Engine and Non–Motor Outward Indications Of Parkinson Disease: A-Tag Observational Research,” printed in Clinical Neuropharmacology:
“Techniques: twenty two individuals using PD [Parkinson’s illness] joining the engine condition center of the tertiary clinic in 2011 to 2012 were examined at standard and half an hour after smoking marijuana utilizing the subsequent battery: Single Parkinson Disease Score Size, visible analogue scale, existing discomfort depth scale, Brief-Type McGill Pain Survey, in addition to Healthcare Marijuana Study National Medication and Booze Research Center Survey.
Outcomes: Imply (SD) complete rating about the engine Single Parkinson Disease Score Size rating enhanced somewhat from 33.1 (13.8) at standard to 23.2 (10.5) after marijuana usage (to EQUALS 5.9; G

You may also like...